Treatment

BPC-157

The regenerative peptide derived from gastric juice with proven healing properties

Definition

BPC-157 (Body Protection Compound 157) is a pentadecapeptide of 15 amino acids derived from a protective protein found in human gastric juice. It works by stimulating nitric oxide synthesis, activating the VEGF pathway (vascular endothelial growth factor), and modulating dopaminergic and serotonergic receptors. Its primary use is the acceleration of healing in tendons, ligaments, muscles, and gastrointestinal tissue.

Detailed explanation

BPC-157 is the most widely researched peptide for musculoskeletal injury recovery. Studies published in the Journal of Physiology-Paris show that it accelerates tendon healing by up to 40% in experimental models, with histologically documented improvements in collagen organisation.

Its mechanisms of action include: stimulation of nitric oxide synthesis in vascular endothelium, direct activation of angiogenesis via VEGF, protection of the gastrointestinal lining against NSAID- or stress-induced injury, and neuroprotective effects through dopaminergic modulation.

In longevity protocols, it is typically administered at doses of 250–500 mcg/day subcutaneously or intramuscularly, in cycles of 4–8 weeks. For acute injuries, some protocols combine the subcutaneous route with local intramuscular injection at the site of injury.

Safety in humans is well-tolerated, with no serious adverse effects documented in the available literature.

Related terms

Therapeutic Peptidestb 500secretagogos gh

Interested in related treatments?

Generate My Protocol

Content created by the LongevityMap editorial team based on peer-reviewed scientific literature. Sources: PubMed, Cochrane Library. This content does not replace professional medical advice. Our team · Methodology